Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Role of Beta-Blockade During Cardiac CT in Patients with Atrial Fibrillation
2025-523391-22-01Phase 4Authorised
- Sponsor
- Semmelweis University
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of carvedilol in Atrial fibrillation (AFib) and coronary arteriosclerosis, sponsored by Semmelweis University. Planned start Oct 2025; status: authorised.
02
Drugs
carvedilol
03
Conditions
Atrial fibrillation (AFib)coronary arteriosclerosis
Beyond the preview
Go deeper on 2025-523391-22-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523391-22-01.